- Conditions
- Diabetic Nephropathy
- Interventions
- Placebo, LY3016859
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2015
- U.S. locations
- 6
- States / cities
- Clearwater, Florida • Omaha, Nebraska • Bethlehem, Pennsylvania + 3 more
Source: ClinicalTrials.gov public record
Updated Sep 18, 2019 · Synced May 22, 2026, 12:16 AM EDT